The roles of apolipoprotein e, lipids, and glucose in the pathogenesis of Alzheimer’s Disease

21Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Although the mechanisms by which Alzheimer’s disease (AD) occurs remains unclear, it is widely accepted that both genetic and nongenetic components contribute to the pathogenesis of AD, especially the sporadic form of the disease. Nongenetic risk factors include diabetes and dyslipidemia, which are associated with impaired glucose and lipid metabolism, respectively. Apolipoprotein E (ApoE), one of the major lipid carriers in the brain, is the strongest genetic risk factor for late-onset AD. Several studies indicate that ApoE isoforms differentially affect not only lipid metabolism but also glucose metabolism or related pathways, suggesting that these risk factors contribute to the pathogenesis of AD through some common mechanisms. In this chapter, we discuss the roles of ApoE, lipids, and glucose in the pathogenesis of AD by considering their potential interactions.

Cite

CITATION STYLE

APA

Shinohara, M., & Sato, N. (2019). The roles of apolipoprotein e, lipids, and glucose in the pathogenesis of Alzheimer’s Disease. In Advances in Experimental Medicine and Biology (Vol. 1128, pp. 85–101). Springer New York LLC. https://doi.org/10.1007/978-981-13-3540-2_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free